Cage Pharma Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Series A
- (Upcoming)
- Investors
-
2
Cage Pharma General Information
Description
Operator of a biopharmaceutical firm intended to develop new drugs targeting the metabolism of tumors. The company's firm uses a novel formulation to target cancer by directly attacking one of its key hallmarks, tumor glycolysis, enabling medical practitioners to achieve efficacy as an anti-cancer agent with a controlled and mild toxicity profile.
Contact Information
Website
www.cagepharma.comCorporate Office
- Baltimore, MD
- United States
Corporate Office
- Baltimore, MD
- United States
Cage Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | Upcoming | Clinical Trials - Phase 1 | ||||
| 3. Later Stage VC | 31-May-2024 | Completed | Clinical Trials - Phase 1 | |||
| 2. Seed Round | 26-Apr-2017 | $2M | $2M | Completed | Clinical Trials - Phase 1 | |
| 1. Accelerator/Incubator | Completed | Startup |
Cage Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Cage Pharma Comparisons
Industry
Financing
Details
Cage Pharma Competitors (38)
One of Cage Pharma’s 38 competitors is Innovimmune Biotherapeutics, a Accelerator/Incubator Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Innovimmune Biotherapeutics | Accelerator/Incubator Backed | New York, NY | ||||
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
| NGM Biopharmaceuticals | Private Equity-Backed | South San Francisco, CA | ||||
| NexImmune | Formerly VC-backed | Gaithersburg, MD |
Cage Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cage Pharma Patents
Cage Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2555767-A2 | Methods of treatment using 3-bromopyruvate and other selective inhibitors of atp production | Inactive | 06-Apr-2010 | ||
| US-20130046019-A1 | Methods of treatment using 3-bromopyruvate and other selective inhibitors of atp production | Inactive | 06-Apr-2010 | ||
| US-20150359764-A1 | Methods of treatment using 3-bromopyruvate and other selective inhibitors of atp production | Inactive | 06-Apr-2010 | ||
| JP-2017125031-A | Methods of treatment using 3-bromopyruvate and other selective inhibitors of atp production | Pending | 06-Apr-2010 | ||
| EP-2555767-A4 | Methods of treatment using 3-bromopyruvate and other selective inhibitors of atp production | Inactive | 06-Apr-2010 | A61K31/19 |
Cage Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cage Pharma Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Catalio Capital Management | Venture Capital | Minority | ||
| Johns Hopkins Technology Ventures | Accelerator/Incubator | Minority |
Cage Pharma FAQs
-
When was Cage Pharma founded?
Cage Pharma was founded in 2017.
-
Where is Cage Pharma headquartered?
Cage Pharma is headquartered in Baltimore, MD.
-
What is the size of Cage Pharma?
Cage Pharma has 2 total employees.
-
What industry is Cage Pharma in?
Cage Pharma’s primary industry is Drug Discovery.
-
Is Cage Pharma a private or public company?
Cage Pharma is a Private company.
-
What is Cage Pharma’s current revenue?
The current revenue for Cage Pharma is .
-
How much funding has Cage Pharma raised over time?
Cage Pharma has raised $2.14M.
-
Who are Cage Pharma’s investors?
Catalio Capital Management and Johns Hopkins Technology Ventures have invested in Cage Pharma.
-
Who are Cage Pharma’s competitors?
Innovimmune Biotherapeutics, CytomX Therapeutics, AnTolRx, NGM Biopharmaceuticals, and NexImmune are some of the 38 competitors of Cage Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
